Can We Predict the Degree of Fibrosis in Chronic Hepatitis C Patients Using Routine Blood Tests in Our Daily Practice?
Authors:
- Ramsey C. CheungRCRamsey C. Cheung
- Sue CurrieSCSue Currie
- Hui ShenHSHui Shen
- Edmund J. BiniEBEdmund J. Bini
- Samuel B. HoSHSamuel B. Ho
- Bhupinderjit S. AnandBABhupinderjit S. Anand
- Ke-Qin HuKHKe-Qin Hu
- Teresa L. WrightTWTeresa L. Wright
- Timothy R. MorganTMTimothy R. Morgan
- 1 August 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 42 (7) , 827-834
Abstract
To determine the validity of fibrosis indexes based on simple laboratory tests in daily practice. Fibrosis indexes were developed in referral centers using high-quality data. We compared the performance characteristics of several such indexes with liver biopsies in a cohort of 490 diverse veterans with chronic hepatitis C from 24 centers. All laboratory tests including interpretation of the liver biopsy were done locally. The following indexes were calculated and correlated with a 5-point fibrosis stage (F0-F4) on liver biopsies: platelet counts (<100 or <150×109/L), aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio (AAR), Pohl score, AST-to-platelet ratio index (APRI) and “Lok's model.” Our cohort was predominantly male with 24% blacks, and fibrosis stages of 0, 1, 2, 3, and 4 in 11%, 24%, 28%, 24%, and 13%, respectively. All indexes performed better in predicting advanced (F3-4) than significant (F2-4) fibrosis. When patients with F3-4 were compared to those with F0-2, the area under the receiver operating characteristics curve were 0.534 and 0.641 for platelet count <100 and <150×109/L, respectively, 0.524 for AAR, 0.534 for Pohl score, 0.693 for Lok's model, and 0.765 for APRI. The sensitivity, specificity, and predictive values of APRI and Lok's model were only slightly lower than those reported by the authors using the recommended cutoffs in clinical trial settings. Alcohol use within 12 months, normalization of AST, ALT, and race (blacks/non-blacks) had minimal impact on the performance. AAR, Pohl, and platelet counts <100×109/L have limited ability to predict significant/advanced fibrosis with area under the receiver operating characteristics curve similar to 0.5. However, platelet counts <150×109/L, Lok's model and APRI performed well for advanced fibrosis in our daily practice setting.Keywords
This publication has 30 references indexed in Scilit:
- The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002Annals of Internal Medicine, 2006
- Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus InfectionAmerican Journal of Gastroenterology, 2005
- Predicting cirrhosis in patients with hepatitis C based on standard laboratory testsHepatology, 2005
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003
- Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infectionAmerican Journal of Gastroenterology, 2001
- Relevance of Moderate Isolated Thrombopenia as a Strong Predictive Marker of Cirrhosis in Patients With Chronic Hepatitis C VirusAmerican Journal of Gastroenterology, 2001
- Liver BiopsyNew England Journal of Medicine, 2001
- Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyondHepatology, 2000
- AST/ALT Ratio Predicts Cirrhosis in Patients With Chronic Hepatitis C Virus InfectionAmerican Journal of Gastroenterology, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995